These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31847538)

  • 1. Myeloperoxidase As a Multifaceted Target for Cardiovascular Protection.
    Ramachandra CJA; Ja KPMM; Chua J; Cong S; Shim W; Hausenloy DJ
    Antioxid Redox Signal; 2020 May; 32(15):1135-1149. PubMed ID: 31847538
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease.
    Ndrepepa G
    Clin Chim Acta; 2019 Jun; 493():36-51. PubMed ID: 30797769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?
    Schindhelm RK; van der Zwan LP; Teerlink T; Scheffer PG
    Clin Chem; 2009 Aug; 55(8):1462-70. PubMed ID: 19556446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.
    Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A
    Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease.
    Nussbaum C; Klinke A; Adam M; Baldus S; Sperandio M
    Antioxid Redox Signal; 2013 Feb; 18(6):692-713. PubMed ID: 22823200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease.
    Anatoliotakis N; Deftereos S; Bouras G; Giannopoulos G; Tsounis D; Angelidis C; Kaoukis A; Stefanadis C
    Curr Top Med Chem; 2013; 13(2):115-38. PubMed ID: 23470074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of myeloperoxidase with cardiovascular disease risk factors in prediabetic subjects.
    Mahat RK; Singh N; Rathore V
    Diabetes Metab Syndr; 2019; 13(1):396-400. PubMed ID: 30641731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome.
    Hanikoglu F; Huseyinoglu N; Ozben S; Cort A; Ozdem S; Ozben T
    Int J Neurosci; 2015; 125(9):655-62. PubMed ID: 25180986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Myeloperoxidase in Biomolecule Modification, Chronic Inflammation, and Disease.
    Davies MJ; Hawkins CL
    Antioxid Redox Signal; 2020 May; 32(13):957-981. PubMed ID: 31989833
    [No Abstract]   [Full Text] [Related]  

  • 10. A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients.
    Khalilova IS; Dickerhof N; Mocatta TJ; Bhagra CJ; McClean DR; Obinger C; Kettle AJ
    PLoS One; 2018; 13(3):e0192952. PubMed ID: 29590135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloperoxidase is an early biomarker of inflammation and cardiovascular risk in prepubertal obese children.
    Olza J; Aguilera CM; Gil-Campos M; Leis R; Bueno G; Martínez-Jiménez MD; Valle M; Cañete R; Tojo R; Moreno LA; Gil A
    Diabetes Care; 2012 Nov; 35(11):2373-6. PubMed ID: 22912422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase and coronary arterial disease: from research to clinical practice.
    Roman RM; Wendland AE; Polanczyk CA
    Arq Bras Cardiol; 2008 Jul; 91(1):e11-9. PubMed ID: 18660935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining myeloperoxidase activity and protein concentration in a single assay: Utility in biomarker and therapeutic studies.
    Russell M; Prokoph N; Henderson N; Eketjäll S; Balendran CA; Michaëlsson E; Fidock M; Hughes G
    J Immunol Methods; 2017 Oct; 449():76-79. PubMed ID: 28713008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function.
    Aratani Y
    Arch Biochem Biophys; 2018 Feb; 640():47-52. PubMed ID: 29336940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography--the LURIC study.
    Scharnagl H; Kleber ME; Genser B; Kickmaier S; Renner W; Weihrauch G; Grammer T; Rossmann C; Winkelmann BR; Boehm BO; Sattler W; März W; Malle E
    Int J Cardiol; 2014 Jun; 174(1):96-105. PubMed ID: 24746542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events.
    Wong ND; Gransar H; Narula J; Shaw L; Moon JH; Miranda-Peats R; Rozanski A; Hayes SW; Thomson LE; Friedman JD; Berman DS
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1093-9. PubMed ID: 19761988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significances of peripheral neutrophils CD(55) and myeloperoxidase expression in patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis].
    Zhou XL; Zheng MJ; Shuai ZW; Zhang L; Zhang MM; Chen SY
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):427-432. PubMed ID: 28592042
    [No Abstract]   [Full Text] [Related]  

  • 18. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography.
    Heslop CL; Frohlich JJ; Hill JS
    J Am Coll Cardiol; 2010 Mar; 55(11):1102-9. PubMed ID: 20223364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kacprzak M; Zielinska M
    Int J Cardiol; 2016 Nov; 223():452-457. PubMed ID: 27544604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Myeloperoxidase (MPO)-DNA complexes as marker for Neutrophil Extracellular Traps (NETs) levels and the association with cardiovascular risk factors in the general population.
    Donkel SJ; Wolters FJ; Ikram MA; de Maat MPM
    PLoS One; 2021; 16(8):e0253698. PubMed ID: 34379628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.